Multiple Assemblies exist for SMTL entry 6p5p
Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent; X-RAY DIFFRACTION 3.30 Å

	SMTL ID 6p5p.1 Ligands 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one Polypeptides Rho-associated protein kinase 2 Oligo-state monomer
	SMTL ID 6p5p.2 Ligands 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one Polypeptides Rho-associated protein kinase 2 Oligo-state monomer
	SMTL ID 6p5p.3 Ligands 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one Polypeptides Rho-associated protein kinase 2 Oligo-state monomer
	SMTL ID 6p5p.4 Ligands 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one Polypeptides Rho-associated protein kinase 2 Oligo-state monomer
	SMTL ID 6p5p.5 Ligands 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one Polypeptides Rho-associated protein kinase 2 Oligo-state homo-dimer
	SMTL ID 6p5p.6 Ligands 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one Polypeptides Rho-associated protein kinase 2 Oligo-state homo-dimer